Your SlideShare is downloading. ×
9 20121127 pharmaq ms. kjersti gravningen
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

9 20121127 pharmaq ms. kjersti gravningen

220
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
220
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. PHARMAQThe Blue Economy – sustainable Fisheries andAquaculture for Food Security - Jakarta, 27-11-2012Kjersti Gravningen
  • 2. PHARMAQ’s business idea• We provide environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people
  • 3. Vaccination and disease control in Norwegian fish farming Treatment Prevention
  • 4. PHARMAQ in brief • Head office in Norway • Subsidiaries in the UK, Chile, Turkey and Vietnam • Distributors other countries • 155 employees • 20% of revenue allocated to R&D (≈ USD 15 mill 2012) • Export to >14 countries • >60% market share salmonids 2011
  • 5. A knowledge driven company
  • 6. PHARMAQ ASIA
  • 7. PHARMAQ in Vietnam• 100% owned by PHARMAQ AS• Clinical R&D and S&M• 16 employees• Trained vaccination team• Wet lab for clinical testing• Diagnostic lab
  • 8. Results– after vaccination of pangasiusagainst E. Ictaluri - field observation period 18,00 R 45 R 16,00 40 14,00 35 12,00 30 R % mortality % mortality 10,00 25 8,00 20 6,00 15 4,00 10 V 2,00 5 V 0,00 1 11 21 31 0 1 11 21 31 41 Day post vaccination Day after vacciantion
  • 9. Relevant experience in species and diseases• Pangasius / catfish • Edwardsiella ictaliuri• Asian Sea bass / Barramundi • Aeromonas hydrophila• Tilapia • Streptococcus agalactieae• Grouper • Streotococcus iniae• Cobia • Photobacterium damselae • Flavobacterium / Tenacibaculum sp. • Vibrio sp • VNN
  • 10. Vaccination a good tool for the Blue economy Future production in Indonesia 4500 4000 Vaccines increases 3500 sustainability and 3000 predictability 1000 tons 2500 2000 1500 • Reduces mortality 1000 500 • Reduces use of antibiotics 0 • Improve environment 2010 2014 Grouper 7 20 • Improve growth Sea bass 5 8,5 • Improve food safety Tilapia 492 1243 Catfish 495 2783 Sugama 2011
  • 11. Vaccine development for new regions – Collection of strains – Characterisation – Clinical development – Process development – Safety / Efficacy testing – Formulation – Field tests – Documentation – Sales – Production